Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
THat was one heck of a HUGE buy toward close! Wonder who did that one??!!
There you go. Buy up these darn stocks!
You're doing right because this is the best time to buy. The only fear we have is fear itself. BUy up these stocks.
Excuse me, but ARYC is the best thing that's ever happened to me. All I've ever seen out of stocks since the past 13 years is making promises and nothing happens with the pps except down in the trips the whole time and then they go bankrupt. ARYC has left the .000s range and has kept itself from being down there for a long time.
Good to know and thanks for filling us in on your unexpected visit.
That works for me! Thanks for the email snapshot confirming Mark is working on COVID-19 testing.
Yeah, that sticky really helps the cause. Whoever decides to invest will ignore the sticky though because they already realize the Caveat Emptor on this stock. When I first started investing I took notice of those details and still invested because of the hopeful gains that others would pass up.
Heck yeah! It's a lot better blocking the noise...I mean, you don't agree with a word they say about the company and every time you put a post on they're right there to contradict it. You can't post in peace.
Personally I cleared out the noise and put some on block and so I can think more clearly. At least blocking them works.
Yes sir. That's more like it. Predictions are a killer with this stock for right now that's all I'm saying.
Like I said, I've learned my lesson from last week. We'll see what happens here. I'm tired of predictions for right now. This company needs to get it's act together first. I'm sure that things will work out but I'm also tired of getting my face smashed in with predictions on this stock.
We don't want to make predictions that we can't hold to. I've learned my lesson on that one from a week ago. We'll see.
Well it looks like we're moving back up. Hmmm.
I understand that frustration sets in. I know it does with me. Like I said, I thought for sure this was a bullish pattern but we’ll see what happens tomorrow.
I completely understand your position and I thought for sure this was headed north. I was wondering how this bullish condition was going to work out without news. Just my thoughts here. We'll see how tomorrow goes. I'm not selling. I'll lose all my shares because I know this company is real.
There's no pumping to that...it's the truth.
And don't forget Arrayit is listed with the FDA...that's a very good sign:
Straight from the FDA website:
ArrayIT’s FDA DUNS NUMBER: 962379470 https://www.accessdata.fda.gov/scripts/sda/sdDetailNavigation.cfm?sd=srolist&id=9F5ABABF101B987CE053564DA8C03211&rownum=1 https://www.fda.gov/about-fda/ethics/listing-significantly-regulated-organizations-sro A publicly traded company, US or foreign stock exchange, is added to the SRO List if it meets either of the following criteria: It is an organization for which the sales of products regulated by the Food and Drug Administration (FDA) constitute ten percent or more of annual gross sales in the organization's previous fiscal year; An organization that does not have a record of sales of FDA-regulated products will be deemed to be significantly regulated if its operations are predominately in fields regulated by FDA, or if its research, development, or other business activities are reasonably expected to result in the development of products that are regulated by FDA.
Very good find!
Disregard my thoughts there. I'll wait and see.
Yes sir, it is. :)
I'll agree with you on those figures. I'm thinking .03 by Friday or Monday but close to what you stated.
I will say this StockDetective, you bring a great service to this board with MUCH DD. It doesn't go unnoticed.
Personally I don't see .03 today. If the bullish pattern keeps going I see .03 by either Friday or Monday. Just my thought anyway.
That's what I see too. There's volume but not enough to flip at this point. You need heavy volume to flip and I'm not seeing that at this time.
Yeah, I recall someone saying this would go down to .005 again. Ain't happening. Wishful thinking? Yes.
Yeah, this is looking good! Let’s see how this bullish pattern goes.
Yep, it’s looking good.
Yep, they did.
Slice the word "further" anyway you want but further means EXACTLY what the judge said it meant."...from attempting to further convert shares", plain and simple.
Yes agreed. And I don't know why some on here cannot seem to comprehend the judges order. It clearly states that the order was given to keep Iconic from further converting shares. How many shares did they already convert that they have to buy back???
I agree with that. Make Iconic pay bigtime to buyback those shares they took.
This is why I pretty much stop posting because all the arguments is getting us nowhere.
I agree. "FROM FURTHER CONVERTING" means Iconic has converted some shares, but how many is uncertain.
We have always said, and will continue to say, don't necessarily trust what is put on this board. Do your own DD and everything is fine. There's about 50% of the stuff put on this board you can trust and the other part is just false and misleading.
Global Allergy Diagnostics Market Growth, Revenue, Trends, Shares, Key Players and Segment Forecast Analysis 2018 – 2026
https://galusaustralis.com/2020/01/349621/global-allergy-diagnostics-market-growth-revenue-trends-shares-key-players-and-segment-forecast-analysis-2018-2026/
DNA MICROARRAY MARKET 2020-2026 KNOW WHAT TREND WILL POSITIVELY IMPACT MARKET GROWTH?
https://jewishlifenews.com/global-market/dna-microarray-market-2020-2026-know-what-trend-will-positively-impact-market-growth/
Quote:
______________________________________________________________________
Key Players:
Illumnia
Scienion AG
Arrayit
Roche NimbleGen
Agilent Technologies
Affymetrix
sengenics
Savyon Diagnostics
WaferGen
Applied Microarrays
Luminex Corporation
Gyros AB
ProteoGenix
Discerna
Biometrix Technology
NextGen Sciences, PLC.,
________________________________________________________________________
TeleMed-VA
https://optimumallergysolutions.com/telemed-va/
https://storage.googleapis.com/wzukusers/user-27922100/documents/5be9c697a0feacHGfCzT/01)%20PAS%20-%20Sales%20-%20Sample%20Report%20-%20110118-2.pdf
Veterans’ Use of VA Telehealth Services Increased Significantly in Fiscal Year 2019
https://connectedcare.va.gov/whats-new/technology/veterans’-use-va-telehealth-services-increased-significantly-fiscal-year-2019
Yep, no problem.
This is the option ARYC checked on the form 15.
Rule 240.12h-3- Suspension of duty to file reports under section 15(d).
§ 240.12h-3 Suspension of duty to file reports under section 15(d).
(a) Subject to paragraphs (c) and (d) of this section, the duty under section 15(d) to file reports required by section 13(a) of the Act with respect to a class of securities specified in paragraph (b) of this section shall be suspended for such class of securities immediately upon filing with the Commission a certification on Form 15 (17 CFR 249.323) if the issuer of such class has filed all reports required by section 13(a), without regard to Rule 12b-25 (17 CFR 249.322), for the shorter of its most recent three fiscal years and the portion of the current year preceding the date of filing Form 15, or the period since the issuer became subject to such reporting obligation. If the certification on Form 15 is subsequently withdrawn or denied, the issuer shall, within 60 days, file with the Commission all reports which would have been required if such certification had not been filed.
(b) The classes of securities eligible for the suspension provided in paragraph (a) of this section are:
(1) Any class of securities, other than any class of asset-backed securities, held of record by:
(i) Fewer than 300 persons, or in the case of a bank; a savings and loan holding company, as such term is defined in section 10 of the Home Owners' Loan Act (12 U.S.C. 1461); or a bank holding company, as such term is defined in section 2 of the Bank Holding Company Act of 1956 (12 U.S.C. 1841), 1,200 persons; or
(ii) Fewer than 500 persons, where the total assets of the issuer have not exceeded $10 million on the last day of each of the issuer's three most recent fiscal years; and
(2) Any class or securities deregistered pursuant to section 12(d) of the Act if such class would not thereupon be deemed registered under section 12(g) of the Act or the rules thereunder.
Note to paragraph (B):
The suspension of classes of asset-backed securities is addressed in § 240.15d-22.
(c) This section shall not be available for any class of securities for a fiscal year in which a registration statement relating to that class becomes effective under the Securities Act of 1933, or is required to be updated pursuant to section 10(a)(3) of the Act, and, in the case of paragraph (b)(1)(ii), the two succeeding fiscal years; Provided, however, That this paragraph shall not apply to the duty to file reports which arises solely from a registration statement filed by an issuer with no significant assets, for the reorganization of a non-reporting issuer into a one subsidiary holding company in which equity security holders receive the same proportional interest in the holding company as they held in the non-reporting issuer, except for changes resulting from the exercise of dissenting shareholder rights under state law.
(d) The suspension provided by this rule relates only to the reporting obligation under section 15(d) with respect to a class of securities, does not affect any other duties imposed on that class of securities, and shall continue as long as either criteria (i) or (ii) of paragraph (b)(1) is met on the first day of any subsequent fiscal year; Provided, however, That such criteria need not be met if the duty to file reports arises solely from a registration statement filed by an issuer with no significant assets in a reorganization of a non-reporting company into a one subsidiary holding company in which equity security holders receive the same proportional interest in the holding company as they held in the non-reporting issuer except for changes resulting from the exercise of dissenting shareholder rights under state law.
(e) If the suspension provided by this section is discontinued because a class of securities does not meet the eligibility criteria of paragraph (b) of this section on the first day of an issuer's fiscal year, then the issuer shall resume periodic reporting pursuant to section 15(d) of the Act by filing an annual report on Form 10-K for its preceding fiscal year, not later than 120 days after the end of such fiscal year.
[49 FR 12689, Mar. 30, 1984, as amended at 51 FR 25362, July 14, 1986; 61 FR 21356, May 9, 1996; 72 FR 16956, Apr. 5, 2007; 73 FR 975, Jan. 4, 2008; 76 FR 52555, Aug. 23, 2011; 81 FR 28706, May 10, 2016]
https://www.law.cornell.edu/cfr/text/17/240.12h-3